STOCK TITAN

[Form 3] Ingevity Corp Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Ingevity Corp senior vice president of operations Clarence Reid Clontz, Jr. reported his beneficial ownership in the company as of the stated event date. He directly holds 7,029 shares of common stock.

He also holds employee stock options granted under the Ingevity Corporation 2016 Omnibus Incentive Plan. These options cover 217 shares at $53.11 per share that vested in full on February 27, 2020, 496 shares at $74.91 per share that vested in full on February 28, 2021, and 351 shares at $115.22 per share that vested in three equal installments between February 28, 2020 and February 28, 2022.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Clontz Clarence Reid Jr.

(Last) (First) (Middle)
C/O INGEVITY CORPORATION 4920 O'HEAR AVE
SUITE 400

(Street)
NORTH CHARLESTON SC 29405

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
12/08/2025
3. Issuer Name and Ticker or Trading Symbol
Ingevity Corp [ NGVT ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP, Operations
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 7,029 D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right-to-buy) 02/27/2020(1) 02/27/2027 Common Stock 217 $53.11 D
Employee Stock Option (right-to-buy) 02/28/2021(2) 02/28/2028 Common Stock 496 $74.91 D
Employee Stock Option (right-to-buy) 02/28/2022(3) 02/28/2029 Common Stock 351 $115.22 D
Explanation of Responses:
1. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 27, 2020.
2. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested in full on February 28, 2021.
3. These options are granted pursuant to the Ingevity Corporation 2016 Omnibus Incentive Plan. Such options vested ratably in three equal installments. The first installment vested on February 28, 2020; the second installment vested on February 28, 2021; and the third installment vested on February 28, 2022.
Remarks:
Exhibits: Exhibit 24 - Power of Attorney
Clarence Reid Clontz, Jr. By: Mavis G. Huger as Attorney-in-Fact 12/18/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Ingevity Corp

NYSE:NGVT

NGVT Rankings

NGVT Latest News

NGVT Latest SEC Filings

NGVT Stock Data

2.10B
35.35M
1.21%
103.73%
2.04%
Specialty Chemicals
Chemicals & Allied Products
Link
United States
NORTH CHARLESTON